iSpecimen (iSpecimen) EV-to-Revenue

: -0.22 (As of Today)

View and export this data going back to 2021. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, iSpecimen's enterprise value is $-2.19 Mil. iSpecimen's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $9.93 Mil. Therefore, iSpecimen's EV-to-Revenue for today is -0.22.

The historical rank and industry rank for iSpecimen's EV-to-Revenue or its related term are showing as below:

ISPC' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.53 Med: 0.02 Max: 10.22
Current: -0.22

During the past 6 years, the highest EV-to-Revenue of iSpecimen was 10.22. The lowest was -0.53. And the median was 0.02.

ISPC's EV-to-Revenue is ranked better than
96.92% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.03 vs ISPC: -0.22

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-22), iSpecimen's stock price is $0.34. iSpecimen's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.10. Therefore, iSpecimen's PS Ratio for today is 0.31.

iSpecimen EV-to-Revenue Historical Data

The historical data trend for iSpecimen's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iSpecimen Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

3.94

-0.27

-0.03

iSpecimen Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue															-0.27	0.11	0.48	0.02	-0.03

Competitive Comparison

For the Diagnostics & Research subindustry, iSpecimen's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iSpecimen EV-to-Revenue Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, iSpecimen's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where iSpecimen's EV-to-Revenue falls into.

iSpecimen EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

iSpecimen's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-2.189	/	9.928
	=	-0.22

iSpecimen's current Enterprise Value is $-2.19 Mil.
iSpecimen's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.93 Mil.

iSpecimen (NAS:ISPC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

iSpecimen's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.34	/	1.098
	=	0.31

iSpecimen's share price for today is $0.34.
iSpecimen's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.10.

iSpecimen EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of iSpecimen's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

iSpecimen (iSpecimen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iSpecimen Inc (NAS:ISPC) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

450 Bedford Street, Lexington, MA, USA, 02420

Website

https://www.ispecimen.com

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Executives

Benjamin Bielak	officer: Chief Information Officer	450 BEDFORD STREET, LEXINGTON MA 02420
Tracy Curley	officer: Chief Financial Officer	450 BEDFORD STREET, LEXINGTON MA 02420
Joseph J. Basile	director	450 BEDFORD STREET, LEXINGTON MA 02420
Andrew L. Ross	director, 10 percent owner	450 BEDFORD STREET, LEXINGTON MA 02420
Gullans Steven R. Ph.d.	director	C/O EXCEL VENTURE MANAGEMENT, LLC, 800 BOYLSTON ST., STE 2825, BOSTON MA 02199
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090
Obf Investments, Llc	10 percent owner	450 BEDFORD STREET, LEXINGTON MA 02420
Margaret H. Lawrence	director	450 BEDFORD STREET, LEXINGTON MA 02420
George H. Scholl	director	450 BEDFORD STREET, LEXINGTON MA 02420
Christopher Ianelli	director, officer: CEO, President	450 BEDFORD STREET, LEXINGTON MA 02420
Jill Mullan	director, officer: COO, Secretary, Treasurer	450 BEDFORD STREET, LEXINGTON MA 02420